1. Home
  2. GRPN vs PHAT Comparison

GRPN vs PHAT Comparison

Compare GRPN & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$25.53

Market Cap

858.4M

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$12.06

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
PHAT
Founded
2008
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.4M
894.0M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
GRPN
PHAT
Price
$25.53
$12.06
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$33.67
$19.83
AVG Volume (30 Days)
1.7M
917.5K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
$2,843,877,000.00
$175,110,000.00
Revenue This Year
$5.55
$93.04
Revenue Next Year
$6.63
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.93
52 Week Low
$9.17
$7.61
52 Week High
$36.64
$18.31

Technical Indicators

Market Signals
Indicator
GRPN
PHAT
Relative Strength Index (RSI) 67.67 63.61
Support Level $15.97 $10.02
Resistance Level N/A $13.26
Average True Range (ATR) 1.82 0.63
MACD 0.68 0.18
Stochastic Oscillator 76.83 94.26

Price Performance

Historical Comparison
GRPN
PHAT

About GRPN Groupon Inc.

Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: